Match tier
Likely match
Presence
Formerly Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
A
Ayesha Arefin
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Staff fellow Biologist
Formerly Arkansas Affiliated with NCTR through 2023.
8 h-index
10 pubs
214 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Ayesha Arefin's research focuses on developing and validating novel biological models for drug safety assessment. She investigates the use of liver microphysiological systems, including those co-culturing human primary hepatocytes and nonparenchymal liver cells, to study drug-induced liver injury. Arefin has characterized the reproducibility of these systems for assaying drug toxicity, metabolism, and accumulation. Her work also extends to engineered heart tissue derived from human pluripotent stem cells, assessing the reproducibility of drug-induced effects on tissue contractility. Additionally, her publications include work on fabricating flexible membranes for tissue engineering applications and developing microfluidic methods for testing elastomeric membranes.
Metrics
- h-index: 8
- Publications: 10
- Citations: 214
Positions
-
Staff fellow Biologist 2021–presentNational Center for Toxicological Research Department of Systems Biology ORCID
-
Graduate Research Assistant 2011–presentLos Alamos National Laboratory B-10: Biosecurity and Public Health ORCID
-
US Food and Drug Administration 2018–2022ORCID
Selected Publications
-
Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells (2023)
-
Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury (2022)
Collaboration Network
Top Collaborators
Qiang Shi
United States Food and Drug Administration
1 shared publication
In database
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
Lijun Ren
National Center for Toxicological Research
1 shared publication
In database
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
Katy S Papineau
United States Food and Drug Administration
1 shared publication
In database
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
Dustyn A. Barnette
United States Food and Drug Administration
1 shared publication
In database
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
Laura K. Schnackenberg
United States Food and Drug Administration
1 shared publication
In database
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
Jessica J. Hawes
United States Food and Drug Administration (US)
1 shared publication
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
Mark Avigan
Center for Drug Evaluation and Research (US)
1 shared publication
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
Donna L. Mendrick
United States Food and Drug Administration
1 shared publication
In database
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
Lorna Ewart
Emulate (United States) (US)
1 shared publication
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
Janey Ronxhi
Emulate (United States) (US)
1 shared publication
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
Melissa Mendoza
United States Food and Drug Administration (US)
1 shared publication
- Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells
Keri Dame
United States Food and Drug Administration (US)
1 shared publication
- Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells
M. Iveth Garcia
Center for Drug Evaluation and Research (US)
1 shared publication
- Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells
David G. Strauss
United States Food and Drug Administration (US)
1 shared publication
- Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells
Alexandre J. S. Ribeiro
United States Food and Drug Administration (US)
1 shared publication
- Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells
Similar Researchers
Based on overlapping research topics
Dayton M. Petibone
National Center for Toxicological Research
Drug-Induced Hepatotoxicity and Protection
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Allyson Gaskill
University of Arkansas at Fayetteville
Tissue Engineering and Regenerative Medicine
Disease Models, Animal
Health Sciences Research and Education
Grady Dunlap
University of Arkansas at Fayetteville
Tissue Engineering and Regenerative Medicine
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Katy S Papineau
National Center for Toxicological Research
Drug-Induced Hepatotoxicity and Protection
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Qiang Shi
National Center for Toxicological Research
Drug-Induced Hepatotoxicity and Protection
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Evie Liebbe
University of Arkansas at Fayetteville
Disease Models, Animal
Materials Science Research
Health Sciences Research and Education